{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3342, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de074-6acf-732b-81a5-1dbf178e8337", "docSlug": "9d19b5dfbd6247810e8962f73b7b797b", "documentTitle": "Taboola | Investor Presentation Deck | 64 slides", "authorId": "taboola", "authorName": "Taboola", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 60, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The table highlights the delta between cash flow and ex-TAC gross profit, demonstrating the impact of upfront payments on cash flow.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6acf-732b-81a5-1dbf178e8337/60", "deckHref": "/decks/019de074-6acf-732b-81a5-1dbf178e8337", "deckAnchorHref": "/decks/019de074-6acf-732b-81a5-1dbf178e8337#slide-60", "loopMatches": [], "arcBeatMatches": [ { "to": 64, "from": 37, "beatId": "f0b14658-5378-4287-8302-a9dc0874388f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Financial performance and guidance", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6acf-732b-81a5-1dbf178e8337", "docSlug": "9d19b5dfbd6247810e8962f73b7b797b", "documentTitle": "Taboola | Investor Presentation Deck | 64 slides", "authorId": "taboola", "authorName": "Taboola", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 61, "slideType": "appendix_data", "function": "analyze_data", "notes": "Financial data presented in millions of dollars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6acf-732b-81a5-1dbf178e8337/61", "deckHref": "/decks/019de074-6acf-732b-81a5-1dbf178e8337", "deckAnchorHref": "/decks/019de074-6acf-732b-81a5-1dbf178e8337#slide-61", "loopMatches": [], "arcBeatMatches": [ { "to": 64, "from": 37, "beatId": "f0b14658-5378-4287-8302-a9dc0874388f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Financial performance and guidance", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6acf-732b-81a5-1dbf178e8337", "docSlug": "9d19b5dfbd6247810e8962f73b7b797b", "documentTitle": "Taboola | Investor Presentation Deck | 64 slides", "authorId": "taboola", "authorName": "Taboola", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 62, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table shows ranges for financial metrics in millions of dollars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6acf-732b-81a5-1dbf178e8337/62", "deckHref": "/decks/019de074-6acf-732b-81a5-1dbf178e8337", "deckAnchorHref": "/decks/019de074-6acf-732b-81a5-1dbf178e8337#slide-62", "loopMatches": [], "arcBeatMatches": [ { "to": 64, "from": 37, "beatId": "f0b14658-5378-4287-8302-a9dc0874388f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Financial performance and guidance", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6acf-732b-81a5-1dbf178e8337", "docSlug": "9d19b5dfbd6247810e8962f73b7b797b", "documentTitle": "Taboola | Investor Presentation Deck | 64 slides", "authorId": "taboola", "authorName": "Taboola", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 63, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard financial disclosure regarding non-GAAP measures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6acf-732b-81a5-1dbf178e8337/63", "deckHref": "/decks/019de074-6acf-732b-81a5-1dbf178e8337", "deckAnchorHref": "/decks/019de074-6acf-732b-81a5-1dbf178e8337#slide-63", "loopMatches": [], "arcBeatMatches": [ { "to": 64, "from": 37, "beatId": "f0b14658-5378-4287-8302-a9dc0874388f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Financial performance and guidance", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6acf-732b-81a5-1dbf178e8337", "docSlug": "9d19b5dfbd6247810e8962f73b7b797b", "documentTitle": "Taboola | Investor Presentation Deck | 64 slides", "authorId": "taboola", "authorName": "Taboola", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 64, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6acf-732b-81a5-1dbf178e8337/64", "deckHref": "/decks/019de074-6acf-732b-81a5-1dbf178e8337", "deckAnchorHref": "/decks/019de074-6acf-732b-81a5-1dbf178e8337#slide-64", "loopMatches": [], "arcBeatMatches": [ { "to": 64, "from": 37, "beatId": "f0b14658-5378-4287-8302-a9dc0874388f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Financial performance and guidance", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/uEi3i47DMoNv3VRGWkWrlN26qGzaH1WltL4kPT-Dzx8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZTk5ODVmZmUwOTU3YWUxZmNkNGRkM2JlNGMzZTY1NS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/1", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/4pX_RjNdQ7E7RL-ajEwXMIR6sq5RnuPpnhjbjOXCxpI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZTk5ODVmZmUwOTU3YWUxZmNkNGRkM2JlNGMzZTY1NS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/KZ1CahBeEMxcAOg9Zmsj-E5peBwOlmmxYs0Ux9EGtmo/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZTk5ODVmZmUwOTU3YWUxZmNkNGRkM2JlNGMzZTY1NS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/aSBCVbNqvPaHCJloIqv1FeHpaoI5xoHElQOud3QBjLE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZTk5ODVmZmUwOTU3YWUxZmNkNGRkM2JlNGMzZTY1NS9wMDAxLnBuZw" }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/2", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "key_messages", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/3", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_messages", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/4", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses stacked bar charts for revenue composition and simple bar charts for session volume.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/5", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide shows a positive trend in revenue growth and a reduction in Adjusted EBITA loss.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/6", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a dual-chart layout to compare revenue composition and profitability trends.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/7", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide shows a decline in Consumer revenue while Payor and DTE revenue show consistent growth throughout 2022.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/8", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses three distinct bar charts to illustrate cost reduction and EBITDA improvement trends.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/9", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a four-column layout to categorize strategic operational focus areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/10", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/11", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/12", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/13", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/14", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6b71-71da-942a-68e865b144c0", "docSlug": "3e9985ffe0957ae1fcd4dd3be4c3e655", "documentTitle": "Talkspace | Results Presentation Deck | 15 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes detailed footnotes explaining financial income and non-recurring expenses.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6b71-71da-942a-68e865b144c0/15", "deckHref": "/decks/019de074-6b71-71da-942a-68e865b144c0", "deckAnchorHref": "/decks/019de074-6b71-71da-942a-68e865b144c0#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/CiSvF8ZIt7pQPiZYGpDPiyVcQNlmqbFewtp6cw2qpSg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjkzMjFjMzdkMjZkZGUyZTVhNzViNTNmMTk1ZWY5Yy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/1", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "10b7d6da-0202-4ef1-bc86-a1a55be52a9d", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Current Reality (Pain)", "beatSlug": "transformation-tale-current-reality-pain", "evidence": "Slides 1-5 set the stage for Theravance Biopharma's current state and challenges", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/P9ruqmQbRw6SXdxttuwWjf5w7gHjP82-Zv3Wae7-B8c/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjkzMjFjMzdkMjZkZGUyZTVhNzViNTNmMTk1ZWY5Yy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/eJe7n-PxZsMzvHNGnnbiDmFL98rOpdn9ncpEHNSRnXI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjkzMjFjMzdkMjZkZGUyZTVhNzViNTNmMTk1ZWY5Yy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/C2sKaZPxh6gzC8b0zHMIQSSKiLM2AL1vj95L5tudbvg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjkzMjFjMzdkMjZkZGUyZTVhNzViNTNmMTk1ZWY5Yy9wMDAxLnBuZw" }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/2", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "10b7d6da-0202-4ef1-bc86-a1a55be52a9d", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Current Reality (Pain)", "beatSlug": "transformation-tale-current-reality-pain", "evidence": "Slides 1-5 set the stage for Theravance Biopharma's current state and challenges", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/3", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "10b7d6da-0202-4ef1-bc86-a1a55be52a9d", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Current Reality (Pain)", "beatSlug": "transformation-tale-current-reality-pain", "evidence": "Slides 1-5 set the stage for Theravance Biopharma's current state and challenges", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a three-column layout to summarize corporate actions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/4", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "10b7d6da-0202-4ef1-bc86-a1a55be52a9d", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Current Reality (Pain)", "beatSlug": "transformation-tale-current-reality-pain", "evidence": "Slides 1-5 set the stage for Theravance Biopharma's current state and challenges", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a three-column layout to categorize corporate objectives.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/5", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "10b7d6da-0202-4ef1-bc86-a1a55be52a9d", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Current Reality (Pain)", "beatSlug": "transformation-tale-current-reality-pain", "evidence": "Slides 1-5 set the stage for Theravance Biopharma's current state and challenges", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/6", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses two bar charts to illustrate growth trends over five quarters.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/7", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-7", "loopMatches": [ { "to": 7, "from": 7, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "611002cb-ed2e-4777-af3b-18eb1fe10450", "evidence": "The slide presents YUPELRI's growth as a key achievement", "position": 1, "objective": "Highlight YUPELRI's growing net sales and hospital volume as a quick win", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a line chart for hospital share and a combo bar/line chart for community share to illustrate market penetration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/8", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a clinical trial methodology using a timeline-based process flow.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/9", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "cover", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/10", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a two-part structure: a top section for market sizing/segmentation and a bottom section for a competitive product comparison table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/11", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The chart is a forest plot showing LS Mean differences with 95% confidence intervals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/12", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "other", "function": "present_framework", "notes": "The slide uses a timeline-based process diagram to illustrate the clinical trial structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/13", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/14", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "kpi_overview", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/15", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide highlights specific cash flow activities like tax payments and share buybacks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/16", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart shows a significant reduction in operating expenses from 2020 to 2023 guidance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/17", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The table displays projected royalties and milestones for 2023-2026. The slide highlights the transition of royalty payments back to Theravance Biopharma starting in 2029.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/18", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "key_messages", "function": "summarize", "notes": "Uses a curved arrow diagram to represent a progression of value drivers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/19", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "d5542c65-e352-4522-bba8-062503c55e06", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 6-19 present the company's vision and growth opportunities", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "other", "function": "other", "notes": "Slide 20 of the presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/20", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "a787cdd9-f5b1-4924-8826-e957eaed06be", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "The Bridge", "beatSlug": "transformation-tale-the-bridge", "evidence": "Slides 20-25 provide a bridge between the current state and future vision", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard pharmaceutical product disclosure slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/21", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "a787cdd9-f5b1-4924-8826-e957eaed06be", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "The Bridge", "beatSlug": "transformation-tale-the-bridge", "evidence": "Slides 20-25 provide a bridge between the current state and future vision", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "other", "function": "establish_context", "notes": "Includes a footnote regarding market research methodology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/22", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "a787cdd9-f5b1-4924-8826-e957eaed06be", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "The Bridge", "beatSlug": "transformation-tale-the-bridge", "evidence": "Slides 20-25 provide a bridge between the current state and future vision", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/23", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "a787cdd9-f5b1-4924-8826-e957eaed06be", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "The Bridge", "beatSlug": "transformation-tale-the-bridge", "evidence": "Slides 20-25 provide a bridge between the current state and future vision", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "nominee_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/24", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "a787cdd9-f5b1-4924-8826-e957eaed06be", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "The Bridge", "beatSlug": "transformation-tale-the-bridge", "evidence": "Slides 20-25 provide a bridge between the current state and future vision", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/25", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "a787cdd9-f5b1-4924-8826-e957eaed06be", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "The Bridge", "beatSlug": "transformation-tale-the-bridge", "evidence": "Slides 20-25 provide a bridge between the current state and future vision", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes abbreviations for COPD, nOH, and PTE in the footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/26", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "customer_journey", "function": "size_opportunity", "notes": "The funnel visualizes the drop-off from total diagnosed COPD patients to those currently on YUPELRI.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/27", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "other", "function": "other", "notes": "Slide lists specific academic abstracts presented at the 33rd International Symposium on the Autonomic Nervous System.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/28", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "before_after", "function": "present_solution", "notes": "The slide uses a before-after framework to justify a strategic pivot in clinical trial focus.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/29", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-29", "loopMatches": [ { "to": 29, "from": 29, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "7826842e-2e9b-4a36-849d-9c76e7c2f257", "evidence": "The before-after slide effectively communicates the benefits of Ampreloxetine treatment", "position": 0, "objective": "Illustrate the potential for broad symptomatic improvement for MSA patients", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a detailed table for Trelegy Ellipta royalties and milestones by year.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/30", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6c10-759a-a503-c8b869115e9a", "docSlug": "3f9321c37d26dde2e5a75b53f195ef9c", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 31 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes cash position, income statement items, and adjusted operating expenses excluding share-based compensation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6c10-759a-a503-c8b869115e9a/31", "deckHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a", "deckAnchorHref": "/decks/019de074-6c10-759a-a503-c8b869115e9a#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6d01-715c-8e28-cf83974ae2ec", "docSlug": "60b25247679e74d9c12b45ec8c79d642", "documentTitle": "XP Inc | Results Presentation Deck | 23 slides", "authorId": "xp-inc", "authorName": "XP Inc", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/LiaNKEfScRQTEIPZnrCj4DV1Uzyu8TFMl9kf_0zpZIQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MGIyNTI0NzY3OWU3NGQ5YzEyYjQ1ZWM4Yzc5ZDY0Mi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6d01-715c-8e28-cf83974ae2ec/1", "deckHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec", "deckAnchorHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/qg6W3j3F2jwB1Fl0vxGArqrniQ7WKePx9eWNeqH0Qjg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MGIyNTI0NzY3OWU3NGQ5YzEyYjQ1ZWM4Yzc5ZDY0Mi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/bljnKEOmnyaRQSbjHBMPqvGxM5y3HB0exhBrsxd6g9U/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MGIyNTI0NzY3OWU3NGQ5YzEyYjQ1ZWM4Yzc5ZDY0Mi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/zymbc3cR7UVBWSqzFX1OcuY10eVM50vDZ_gPyKruYKQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MGIyNTI0NzY3OWU3NGQ5YzEyYjQ1ZWM4Yzc5ZDY0Mi9wMDAxLnBuZw" }, { "docId": "019de074-6d01-715c-8e28-cf83974ae2ec", "docSlug": "60b25247679e74d9c12b45ec8c79d642", "documentTitle": "XP Inc | Results Presentation Deck | 23 slides", "authorId": "xp-inc", "authorName": "XP Inc", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6d01-715c-8e28-cf83974ae2ec/2", "deckHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec", "deckAnchorHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6d01-715c-8e28-cf83974ae2ec", "docSlug": "60b25247679e74d9c12b45ec8c79d642", "documentTitle": "XP Inc | Results Presentation Deck | 23 slides", "authorId": "xp-inc", "authorName": "XP Inc", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 3, "slideType": "table_of_contents", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6d01-715c-8e28-cf83974ae2ec/3", "deckHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec", "deckAnchorHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6d01-715c-8e28-cf83974ae2ec", "docSlug": "60b25247679e74d9c12b45ec8c79d642", "documentTitle": "XP Inc | Results Presentation Deck | 23 slides", "authorId": "xp-inc", "authorName": "XP Inc", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 4, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6d01-715c-8e28-cf83974ae2ec/4", "deckHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec", "deckAnchorHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6d01-715c-8e28-cf83974ae2ec", "docSlug": "60b25247679e74d9c12b45ec8c79d642", "documentTitle": "XP Inc | Results Presentation Deck | 23 slides", "authorId": "xp-inc", "authorName": "XP Inc", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 5, "slideType": "before_after", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6d01-715c-8e28-cf83974ae2ec/5", "deckHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec", "deckAnchorHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec#slide-5", "loopMatches": [ { "to": 6, "from": 5, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "29c334c9-2a62-47fd-bfd0-9913432cfb77", "evidence": "The before-after loop on slides 5-6 effectively shows the company's progress", "position": 0, "objective": "Highlight the company's evolution and improved business model", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 6, "from": 5, "beatId": "64cbb367-af59-490b-a09c-c36e66b078ad", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "Slides 5-6 show the company's evolution and positive market environment", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6d01-715c-8e28-cf83974ae2ec", "docSlug": "60b25247679e74d9c12b45ec8c79d642", "documentTitle": "XP Inc | Results Presentation Deck | 23 slides", "authorId": "xp-inc", "authorName": "XP Inc", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 6, "slideType": "before_after", "function": "diagnose_problem", "notes": "The slide contrasts the 2013-2014 period (high cyclicality) with the 2021-2022 period (resilience).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6d01-715c-8e28-cf83974ae2ec/6", "deckHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec", "deckAnchorHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec#slide-6", "loopMatches": [ { "to": 6, "from": 5, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "29c334c9-2a62-47fd-bfd0-9913432cfb77", "evidence": "The before-after loop on slides 5-6 effectively shows the company's progress", "position": 0, "objective": "Highlight the company's evolution and improved business model", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 6, "from": 5, "beatId": "64cbb367-af59-490b-a09c-c36e66b078ad", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "Slides 5-6 show the company's evolution and positive market environment", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6d01-715c-8e28-cf83974ae2ec", "docSlug": "60b25247679e74d9c12b45ec8c79d642", "documentTitle": "XP Inc | Results Presentation Deck | 23 slides", "authorId": "xp-inc", "authorName": "XP Inc", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 7, "slideType": "timeline", "function": "present_solution", "notes": "The slide uses a line chart to represent a timeline of product launches alongside headcount growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6d01-715c-8e28-cf83974ae2ec/7", "deckHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec", "deckAnchorHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "613c882a-2133-460a-a3f7-171f05747355", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 7-9 highlight the company's growth and improved financials", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6d01-715c-8e28-cf83974ae2ec", "docSlug": "60b25247679e74d9c12b45ec8c79d642", "documentTitle": "XP Inc | Results Presentation Deck | 23 slides", "authorId": "xp-inc", "authorName": "XP Inc", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 8, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide highlights growth in both operational capacity (IFAs) and financial scale (Client Assets).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6d01-715c-8e28-cf83974ae2ec/8", "deckHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec", "deckAnchorHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "613c882a-2133-460a-a3f7-171f05747355", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 7-9 highlight the company's growth and improved financials", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-6d01-715c-8e28-cf83974ae2ec", "docSlug": "60b25247679e74d9c12b45ec8c79d642", "documentTitle": "XP Inc | Results Presentation Deck | 23 slides", "authorId": "xp-inc", "authorName": "XP Inc", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 9, "slideType": "kpi_overview", "function": "quantify_opportunity", "notes": "The slide uses a grid of metrics to show current penetration and a list of callouts to explain the strategic value of increasing these numbers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-6d01-715c-8e28-cf83974ae2ec/9", "deckHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec", "deckAnchorHref": "/decks/019de074-6d01-715c-8e28-cf83974ae2ec#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "613c882a-2133-460a-a3f7-171f05747355", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 7-9 highlight the company's growth and improved financials", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }